Impact of a Mobile Application-Based Medication Reminder on Treatment Adherence Among Patients With Chronic Diseases and Memory Impairment: A Nursing Leadership Perspective
1 other identifier
interventional
193
1 country
2
Brief Summary
This study aims to evaluate the impact of using a mobile application-based medication reminder on medication adherence among patients diagnosed with chronic diseases and memory impairment. Adherence to prescribed therapy is a significant challenge for this patient population, often leading to poor health outcomes and increased healthcare costs. From a nursing leadership perspective, innovative digital solutions can play a crucial role in supporting patient self-management. Using a quasi-experimental design, the study will investigate whether a customized mobile reminder system can effectively improve adherence rates and support patients in managing their therapeutic regimens.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2026
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 10, 2026
CompletedFirst Submitted
Initial submission to the registry
July 14, 2026
CompletedFirst Posted
Study publicly available on registry
July 21, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
July 21, 2026
July 1, 2026
4 months
July 14, 2026
July 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Medication Adherence (MMAS-8)
Medication adherence will be assessed using the 8-item Morisky Medication Adherence Scale (MMAS-8). This self-reported tool evaluates patients' behaviors regarding taking their prescribed chronic medications. Total scores range from 0 to 8, where a score of 8 indicates high adherence, 6 to \<8 indicates medium adherence, and \<6 indicates low adherence.
Baseline (pre-intervention) and 3 months post-intervention
Secondary Outcomes (4)
Objective Medication Adherence: Medication Possession Ratio (MPR)
3 months post-intervention
Objective Medication Adherence: Proportion of Days Covered (PDC)
3 months post-intervention
Cognitive Function Status (MMSE)
Baseline
Perceived Nursing Care and Leadership Support
3 months post-intervention.
Study Arms (1)
Mobile Application Group
EXPERIMENTALParticipants in this single-group study will receive training on and utilize a customized mobile application-based medication reminder designed to support adherence to their therapeutic regimens.
Interventions
The intervention consists of a mobile application specifically designed to support medication adherence. It features automated push notifications, customized reminder alerts matching prescribed medication schedules, and tracking logs. Participants will be instructed on how to install, configure, and use the application on their personal smartphones. The system is designed to provide immediate prompts to overcome memory-related adherence barriers.
Eligibility Criteria
You may qualify if:
- Patients diagnosed with one or more chronic diseases requiring regular long-term medication.
- Patients exhibiting mild-to-moderate memory impairment or cognitive decline as screened by the Mini-Mental State Examination (MMSE).
- Patients who personally own and are capable of operating a smartphone or have a primary caregiver willing to manage the mobile application.
- Patients aged 18 years and older.
- Patients who provide voluntary informed consent to participate in the study.
You may not qualify if:
- Patients with severe cognitive impairment or advanced dementia who cannot interact with mobile technology even with caregiver assistance.
- Patients with severe acute clinical complications or unstable psychiatric conditions.
- Patients participating in another concurrent clinical trial or study targeting medication adherence
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mansoura Universitylead
- Al-Azhar Universitycollaborator
- Delta University for Science and Technologycollaborator
Study Sites (2)
Outpatient Clinics, Delta University for Science and Technology
Gamasa, Dakahlia Governorate, Egypt
Outpatient Clinics, Kafr El-Sheikh Hospital
Kafr ash Shaykh, Kafr el-Sheikh Governorate, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of Nursing Administration, Faculty of Nursing, Mansoura University, Egypt
Study Record Dates
First Submitted
July 14, 2026
First Posted
July 21, 2026
Study Start
May 10, 2026
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
September 1, 2026
Last Updated
July 21, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared to ensure the confidentiality and privacy of the patients' medical records and personal information.